Impact of hot flashes on quality of life among postmenopausal women being treated for breast cancer (Q40755896)

23 September 2017

Impact of hot flashes on quality of life among postmenopausal women being treated for breast cancer (English)

1 reference

23 September 2017

1 reference

Stein KD

1

1 reference

23 September 2017

Jacobsen PB

2

1 reference

23 September 2017

Hann DM

3

1 reference

23 September 2017

Greenberg H

4

1 reference

23 September 2017

Lyman G

5

1 reference

23 September 2017

1 June 2000

1 reference

Journal of Pain and Symptom Management

23 September 2017

1 reference

23 September 2017

19

1 reference

23 September 2017

6

1 reference

23 September 2017

436-445

1 reference

Hot flashes: epidemiology and physiology

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900142-1

7 January 2021

Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900142-1

7 January 2021

A Meta-analysis of the Effect of Estrogen Replacement Therapy on the Risk of Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900142-1

7 January 2021

A double-blind trial of tamoxifen plus prednisolone versus tamoxifen plus placebo in postmenopausal women with metastatic breast cancer. A collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900142-1

7 January 2021

The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900142-1

7 January 2021

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900142-1

7 January 2021

Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900142-1

7 January 2021

Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900142-1

7 January 2021

A multidimensional measure of fatigue for use with cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900142-1

7 January 2021

The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900142-1

7 January 2021

Symptoms associated with tamoxifen treatment in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900142-1

7 January 2021

Prospective evaluation of vitamin E for hot flashes in breast cancer survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900142-1

7 January 2021

Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900142-1

7 January 2021

Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900142-1

7 January 2021

10.1016/S0885-3924(00)00142-1

Identifiers

DOI

1 reference

23 September 2017

1 reference